Causes of Pulmonary Edema, Cardiogenic Pulmonary Edema, Non Cardiogenic Pulmonary Edema, Signs and Symptoms of Pulmonary Edema, Diagnosis of Pulmonary Edema, Name of the Test to be conducted to Diagnose Pulmonary Edema, Treatment of Pulmonary Edema and Pr
Abstract
In most of the cases, heart problems are related to the pulmonary edema. Both pulmonary edema and pneumonia are related to a build up of fluid in your lungs. An infection leads to the occurrence of pneumonia. The infection may be bacterial, viral or fungi. Pulmonary edema is generally related to heart diseases, but it shows other possible reasons namely blood transfusion reactions as well as kidney failure. Primary pulmonary edema is divided two groups such as cardiogenic (heart related) group and non cardiogenic (non heart-related) group. High altitude pulmonary edema (HAPE) is observed, if you especially at high altitude or if you are rapidly going up a mountain. Negative pulmonary edema is seen especially after a blockage in your upper airways. Pulmonary edema is classified is classified into sudden (acute) as well as long - term (chronic) types. Blood chemistries, cardiac caterization, chest X ray. Complete blood count (CBC), ECG and pulse oximetry are helpful in diagnosing pulmonary edema. Treatment is also based on iv diuretics, iv inotropes, nitrates and oxygen. Treatment is dependent upon the machines and medications. Antibiotics, steroids, ventilators or respirators are useful in treating pulmonary edema. Prevention of pulmonary edema is based on routine vaccinations, healthy diet along with low salt and regulation of body weight.
Full Text:
PDFReferences
Stanojevic S, Kaminsky DA, Miller MR, Thompson B, Aliverti A, Barjaktarevic I, Cooper BG, Culver B, Derom E, Hall GL, Hallstrand TS, Leuppi JD, MacIntyre N, McCormack M, Rosenfeld M, Swenson ER. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J. 2022 Jul;60(1) [PubMed]
Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J., ATS/ERS Task Force. General considerations for lung function testing. Eur Respir J. 2005 Jul;26(1):153-61. [PubMed]
Sankari A, Bascom A, Oomman S, Badr MS. Sleep disordered breathing in chronic spinal cord injury. J Clin Sleep Med. 2014 Jan 15;10(1):65-72. [PMC free article] [PubMed]
Cooper BG. An update on contraindications for lung function testing. Thorax. 2011 Aug;66(8):714-23. [PubMed]
Ali NA, Nafees AA, Fatmi Z, Azam SI. Dose-response of Cotton Dust Exposure with Lung Function among Textile Workers: MultiTex Study in Karachi, Pakistan. Int J Occup Environ Med. 2018 Jul;9(3):120-128. [PMC free article] [PubMed]
O'Donnell CR, Bankier AA, Stiebellehner L, Reilly JJ, Brown R, Loring SH. Comparison of plethysmographic and helium dilution lung volumes: which is best for COPD? Chest. 2010 May;137(5):1108-15. [PMC free article] [PubMed]
Rhodes CE, Denault D, Varacallo M. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Nov 14, 2022. Physiology, Oxygen Transport. [PubMed]
Trakada G, Kastritis E, Gavriatopoulou M, Velentza L, Fotiou D, Ziogas DC, Panagiotidis I, Eleutherakis-Papaiakovou E, Roussou M, Migkou M, Kanellias N, Ntanasis-Stathopoulos I, Kallianos A, Terpos E, Dimopoulos MA. Pulmonary function abnormalities are common in patients with multiple myeloma and are independently associated with worse outcome. Ann Hematol. 2019 Jun;98(6):1427-1434. [PubMed]
Coates AL, Wanger J, Cockcroft DW, Culver BH, Bronchoprovocation Testing Task Force: Kai-Håkon Carlsen. Diamant Z, Gauvreau G, Hall GL, Hallstrand TS, Horvath I, de Jongh FHC, Joos G, Kaminsky DA, Laube BL, Leuppi JD, Sterk PJ. ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests. Eur Respir J. 2017 May;49(5) [PubMed]
Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, McCormack MC, Carlin BW, Sciurba FC, Pitta F, Wanger J, MacIntyre N, Kaminsky DA, Culver BH, Revill SM, Hernandes NA, Andrianopoulos V, Camillo CA, Mitchell KE, Lee AL, Hill CJ, Singh SJ. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014 Dec;44(6):1428-46. [PubMed]
Bittner V, Weiner DH, Yusuf S, Rogers WJ, McIntyre KM, Bangdiwala SI, Kronenberg MW, Kostis JB, Kohn RM, Guillotte M. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. JAMA. 1993 Oct 13;270(14):1702-7. [PubMed]
Bohannon RW, Crouch R. Minimal clinically important difference for change in 6-minute walk test distance of adults with pathology: a systematic review. J Eval Clin Pract. 2017 Apr;23(2):377-381. [PubMed]
Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J., ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005 Aug;26(2):319-38. [PubMed]
Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. Interpretative strategies for lung function tests. Eur Respir J. 2005 Nov;26(5):948-68. [PubMed]
Tashkin DP, Celli B, Decramer M, Liu D, Burkhart D, Cassino C, Kesten S. Bronchodilator responsiveness in patients with COPD. Eur Respir J. 2008 Apr;31(4):742-50. [PubMed]
Paine NJ, Joseph MF, Bacon SL, Julien CA, Cartier A, Ditto B, Favreau H, Lavoie KL. Association Between Depression, Lung Function, and Inflammatory Markers in Patients with Asthma and Occupational Asthma. J Occup Environ Med. 2019 Jun;61(6):453-460. [PubMed]
Refbacks
- There are currently no refbacks.